Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Shiller Sees Hint of Slowdown in Home Prices
28:57 - Yale University Professor of Economics and Finance Robert Shiller discusses the latest home price data in the August S&P CoreLogic Case-Shiller Index. He speaks on "Bloomberg Daybreak: Americas." (Source: Bloomberg)
  • Monday's Canadian Stock Movers
  • 'The Shark' Greg Norman Rebrands His Business
  • Goldman's Currie Sees Lower OPEC Deal Probability